FIELD: medicine; ophthalmology.
SUBSTANCE: invention can be used for intravitreal administration of drugs in the presence of senile scleral plaque. To do this, the patient is prepared. The operating field is treated. Local anesthesia is performed. An eyelid expander is put on. The patient's gaze is directed. The eyeball is fixed behind the episclera. The sclera is examined for the presence of senile scleral plaque. The scleropuncture site is marked with a sclerometer. After that, scleropuncture is performed at a distance of at least 4 mm from the edge of the senile scleral plaque and the drug is injected.
EFFECT: invention reduces the risk of adverse outcomes of intravitreal administration of drugs by determining the safe localization of scleropuncture in this category of patients.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR INTRA-VITREAL DRUG ADMINISTRATION IN OPHTHALMOLOGY | 2015 |
|
RU2581219C1 |
| METHOD FOR REDUCING THE INTRAOCULAR PRESSURE AFTER INTRAVITREAL INTRODUCTION OF THE LUCENTIS ANGIOGENESIS INHIBITOR IN NEOVASCULAR GLAUCOMA WITH INTRAOCULAR PRESSURE ABOVE 30 MM HG. AGAINST THE BACKGROUND OF PROLIFERATIVE DIABETIC AND/OR POST-THROMBOTIC RETINOPATHY | 2020 |
|
RU2766718C1 |
| METHOD FOR THE PREVENTION OF CORNEAL COMPLICATIONS AFTER GLAUCOMA SURGERY USING ANTIMETABOLITES | 2022 |
|
RU2782095C1 |
| METHOD OF TREATING SQUINT WITH ATYPICAL INNERVATION OF EXTRAOCULAR MUSCLES | 2010 |
|
RU2447867C1 |
| METHOD FOR PREVENTION OF HAEMORRHAGIC COMPLICATIONS IN SURGICAL MANAGEMENT OF PATIENTS WITH SECONDARY NEOVASCULAR UNCOMPENSATED GLAUCOMA | 2024 |
|
RU2840443C1 |
| METHOD FOR THE TREATMENT OF PERSISTENT EPITHELIAL CORNEAL DEFECT | 2022 |
|
RU2792394C1 |
| METHOD OF SUPRACHOROIDAL ADMINISTRATION OF MEDICINAL PRODUCT FOR UVEAL CYSTIC MACULAR EDEMA | 2023 |
|
RU2805816C1 |
| METHOD OF TREATING NEOVASCULAR GLAUCOMA | 2011 |
|
RU2467733C1 |
| METHOD FOR APPLYING ENZYMOTHERAPY | 2006 |
|
RU2303457C1 |
| METHOD FOR INTRODUCING DRUGS IN SUBSCLERAL WAY | 2003 |
|
RU2238709C1 |
